Electron Activated Dissociation for Biologics Characterization
Protein biologics can serve as targeted therapies, diagnostic biomarkers and invaluable tools for scientific research. However, their characterization remains a challenge in biopharmaceutical workflows.
Electron activated dissociation (EAD) can provide greater insights into protein structure, identify post-translational modifications and assess products’ heterogeneity. Hence, it can support critical decision-making steps during drug development.
This content pack contains a variety of webinar and technical note resources to support you in the rapid, accurate characterization of your protein biologics products.
Download this content pack to discover:
- The latest, preoptimized methods for a variety of characterization workflows
- An intuitive software which supports flexible method optimization
- The latest EAD methods for a variety of characterization workflows